+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid udca decreases serum cholesterol levels ameliorates symptoms and improves biochemical parameters in pediatric patients with chronic intrahepatic cholestasis



Ursodeoxycholic acid udca decreases serum cholesterol levels ameliorates symptoms and improves biochemical parameters in pediatric patients with chronic intrahepatic cholestasis



Gastroenterology 98(5 Part 2): A566




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144937

Download citation: RISBibTeXText


Related references

Effect of ursodeoxycholic acid udca on pruritus and serum cholesterol levels in patients with cholestasis associated with syndromic paucity of intrahepatic bile ducts alagille syndrome. Hepatology 12(4 Part 2): 994, 1990

Ursodeoxycholic acid udca treatment improves liver disease and nutritional state in cystic fibrosis cf patients with chronic cholestasis. Gastroenterology 96(5 Part 2): A586, 1989

Ursodeoxycholic acid udca improves serum albumin levels in chronic active hepatitis. Gastroenterology 98(5 Part 2): A606, 1990

Failure of ursodeoxycholic acid udca to prevent the occurrence of cholestasis in benign recurrent intrahepatic cholestasis bric. Gastroenterology 98(5 Part 2): A578, 1990

Ursodeoxycholic acid udca improves serum protein level in patients with chronic active hepatitis. Hepatology 12(4 Part 2): 998, 1990

Safety evaluation of ursodeoxycholic acid udca in patients with chronic cholestasis. Naunyn-Schmiedeberg's Archives of Pharmacology 339(Suppl.): R119, 1989

Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA). Digestive Diseases and Sciences 41(12): 2417-2422, 1996

Effects of lovastatin ls ursodeoxycholic acid udca and ls plus udca on bile lipid composition in patients with cholesterol ch gallstones. Gastroenterology 102(4 Part 2): A319, 1992

Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 25(3): 519-523, 1997

Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2 kd/kd Mice. Biological and Pharmaceutical Bulletin 40(1): 34-42, 2017

Toxicity of ursodeoxycholic acid udca in chronic cholestasis assessed by quantitative liver function tests. Journal of Hepatology 7(Suppl. 1): S54, 1988

Ursodeoxycholic acid decreases the serum transaminase levels of chronic liver disease patients treated with glycyrrhizin. International Hepatology Communications 6(2): 85-91, 1996

Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 26(6): 1573-1579, 1997

Ursodeoxycholic acid treatment shortens the course of cholestasis in two patients with benign recurrent intrahepatic cholestasis. Gastroenterologia Y Hepatologia 26(7): 421-423, 2003

Effect of ursodeoxycholic acid udca on serum enzymes and liver histology in patients with chronic active hepatitis cah. Journal of Hepatology 13(Suppl. 2): S92, 1991